Financial Reports

2022/2023

As a result of Bluefish Pharmaceuticals being a subsidiary consolidated by Färna Invest AB, Bluefish has, in accordance with current legislation, aligned its financial year with that of the parent company in 2022. The financial year now spans the period from May 1 to April 30. During the transition year, the financial year has been extended and thus covers the period from January 1, 2022, to April 30, 2023.

Therefore, starting from June 2022, only interim reports will be prepared, which will be made available to shareholders upon request.

2021/2022

2020/2021

2019/2020